Plans priced against a single missed catalyst.
A Phase 2 readout can move a stock 80% in a day. Missing one costs more than a year of subscription — the only question is whether you see it before the market does.
Trial
- ClinicalTrials.gov, openFDA and the FDA Orange Book
- Rolling 7-day catalyst history
- 1 email digest per week
- Dashboard access
Analyst
- Every source, including patent and market data
- Full catalyst calendar with trial-status countdowns
- Rolling 12-month history
- Daily email alerts on your watchlist
- Patent-cliff view — US expirations within 12 months
Pro
- Everything in Analyst
- Pipeline versus price-movement correlation
- Competitive pipeline overlap detection
- API access
- 3 seats
- Webhook alerts the moment a trial status changes
Fund
- Everything in Pro
- Unlimited seats
- SSO / SAML
- Bulk export and full history
- Custom coverage universe on request
- Named support and onboarding
Online card checkout is not enabled on this deployment yet — set STRIPE_SECRET_KEY and the plan price ids to switch it on. Until then, choose a plan and we will arrange access.
Primary sources only — ClinicalTrials.gov, openFDA, the FDA Orange Book, SEC EDGAR, Europe PMC and market data, read directly rather than re-summarised by a third party.
Change detection — every sweep is diffed against the last, so a trial moving from recruiting to active is reported as an event rather than buried in a static list.
Catalyst calendar — trial completion dates, PDUFA dates and expected readouts, counted down. The dates that actually move a position.
Patent cliffs — real expiration data from the Orange Book, so the competitive picture is visible years out rather than guessed at.